Developing and Characterization of Chemically Modified RNA Aptamers for Targeting Wild Type and Mutated c-KIT Receptor Tyrosine Kinases

Journal of Medicinal Chemistry
Ala'a S ShraimSaid Ismail

Abstract

The c-KIT receptor represents an attractive target for cancer therapy. Aptamers are emerging as a new promising class of nucleic acid therapeutics. In this study, a conventional SELEX approach was applied against the kinase domain of a group of c-KIT proteins (c-KITWT, c-KITD816V, and c-KITD816H) to select aptamers from a random RNA pool that can bind to the kinase domain of each target with high affinity and can selectively interfere with their kinase activities. Interestingly, our data indicated that one candidate aptamer, called V15, can specifically inhibit the in vitro kinase activity of mutant c-KITD816V with an IC50 value that is 9-fold more potent than the sunitinib drug tested under the same conditions. Another aptamer, named as H5/V36, showed the potential to distinguish between the c-KIT kinases by modulating the phosphorylation activity of each in a distinct mechanism of action and in a different potency.

References

Jan 1, 1995·Biotechnology Annual Review·A D Ellington, R Conrad
Nov 5, 1999·Journal of Molecular Biology·I Tinoco, C Bustamante
Apr 4, 2000·Structure·T Hermann, D J Patel
Nov 30, 2000·Chemistry & Biology·S D SeiwertO C Uhlenbeck
Jun 26, 2003·The Journal of Biological Chemistry·Clifford D MolDuncan E McRee
May 5, 2004·The Journal of Biological Chemistry·Clifford D MolKeith P Wilson
Jul 28, 2004·Proceedings of the National Academy of Sciences of the United States of America·Mirko G TheisMichael Famulok
Oct 30, 2004·Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer·Gautam MaulikRavi Salgia
Oct 18, 2005·Biochemical and Biophysical Research Communications·Robert Roskoski
Jul 18, 2006·Nucleic Acids Research·Oleg KikinParamjeet S Bagga
Oct 12, 2007·Chembiochem : a European Journal of Chemical Biology·Abdellah Allali-HassaniYingfu Li
Feb 20, 2008·Biochemistry. Biokhimii︠a︡·A V Kulbachinskiy
Nov 5, 2008·Methods in Molecular Biology·Sean P RyderJames R Williamson
Jan 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Ketan S GajiwalaGeorge D Demetri
Feb 7, 2009·Journal of Biomolecular Screening·Jingsong YangZhihong Lai
Jan 12, 2010·Assay and Drug Development Technologies·Brad LarsonSaid A Goueli
Jun 23, 2010·Oligonucleotides·Sujin JeongSeong-Wook Lee
Jan 1, 2009·Methods in Enzymology·Sarah A Woodson, Eda Koculi
Dec 1, 2010·Molecular Biology of the Cell·Thomas D Pollard
Mar 15, 2012·Chembiochem : a European Journal of Chemical Biology·Vincent J B RuigrokJohn van der Oost
May 11, 2012·Current Pharmaceutical Design·Vandana Lamba, Indraneel Ghosh
Jun 28, 2012·Methods in Molecular Biology·Alexander V YakhninPaul Babitzke
Sep 7, 2012·Chemical Communications : Chem Comm·Guizhi ZhuWeihong Tan
Sep 20, 2012·Wiley Interdisciplinary Reviews. RNA·Stefan WashietlManolis Kellis
Oct 18, 2012·Physiological Reviews·Johan Lennartsson, Lars Rönnstrand
Jan 1, 2008·Expert Opinion on Drug Discovery·Kurt W VogelBrian A Pollok
May 17, 2013·International Journal of Biological Sciences·Jing LiangHiroshi Sugiyama
Jun 6, 2013·Nucleic Acids Research·Abdullah OzerDavid Shalloway
Jun 28, 2013·The Journal of Biological Chemistry·Shruti AgarwalLars Rönnstrand
Aug 3, 2013·Cold Spring Harbor Perspectives in Biology·Carl-Henrik Heldin, Johan Lennartsson
Oct 15, 2013·Wiley Interdisciplinary Reviews. RNA·Roopa ThaparEdward P Nikonowicz
Nov 1, 2013·Nucleic Acid Therapeutics·Nidaa AbabnehSaid Ismail
Apr 22, 2014·Immunology and Allergy Clinics of North America·Glenn CruseAna Olivera
Jul 9, 2014·Journal of Medicinal Chemistry·Soyoung LeeSungwoo Hong
Aug 12, 2014·International Journal of Molecular Sciences·Mohammad Hojjat-Farsangi
Sep 4, 2014·ACS Chemical Biology·Sabine LennarzGünter Mayer

❮ Previous
Next ❯

Citations

Mar 5, 2020·Molecular Cancer Therapeutics·Sudeep BanerjeePartha Ray

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.